SCHEMBL20209511

SCHEMBL20209511

CC(C)C1CCCCCC(N)C1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.36
SHBG P04278 1/20 0.36
TP53 P04637 1/20 0.33
MMP1 P03956 1/20 0.33
MMP8 P22894 1/20 0.33
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
NISCH Q9Y2I1 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GMNN O75496 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14519171 0.93 MEN1 (0.33) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL20063983 0.93 MEN1 (0.33) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3244901 0.93 MEN1 (0.33) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL18430016 0.93 MEN1 (0.33) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL15686723 0.93 MEN1 (0.33) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL14519180 0.93 MEN1 (0.33) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL15686716 0.93 MEN1 (0.33) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL22003075 0.88 MEN1 (0.31) EPHX1SHBGMEN1CYP1A2CYP3A4
SCHEMBL23818479 0.84 MEN1 (0.31) MEN1CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL22003077 0.84 MEN1 (0.31) MEN1CYP1A2CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10836785-B2 Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2020-11-17 US disclosed
US-20180148464-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10836785-B2 Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues PAICS, DNTT, PNPO EPHX1 4575/4885SHBG 3158/4885TP53 2517/4885
US-20180148464-A1 TETRADENTATE AND OCTAHEDRAL METAL COMPLEXES CONTAINING NAPHTHYRIDINOCARBAZOLE AND ITS ANALOGUES PAICS, DNTT, PNPO EPHX1 4575/4885SHBG 3158/4885TP53 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.